Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most ...

Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...

CRISPR Therapeutics' Q3 saw reduced expenses and slow Casgevy launch, resulting in a revenue miss. Read why I am neutral on ...

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

Researchers in Lithuania present the molecular structure of a new, more-versatile CRISPR system for gene editing.

A new self-eliminating CRISPR tool may help combat insecticide resistance and reduce the number of insecticides being used ...

CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...

CRISPR Therapeutics (CRSP 0.65%) were down 47% from a peak they reached in March. This might be a little surprising to folks ...

The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...

The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

Shares of CRISPR Therapeutics AG (CRSP) have gained 0.8% over the past four weeks to close the last trading session at $51.17, but there could still be a solid upside left in the stock if short-term ...